drugset / Trial / NCT02071381
Phase 1 Study of DDI Between DW330SR and DW1030 in Healthy Male Subjects
Summary
The purpose of this study is to evaluate drugs interactions to compare pharmacokinetics in groups of monotherapy DW330SR, monotherapy DW1030, and coadministration DW330SR and DW1030
Timeline
- Start
- 2014-04
- Primary completion
- 2014-06
- Completion
- 2014-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DW1030 | Unknown | 75 mg | — |
| Subject | DW330SR | Unknown | 45 mg | — |
Indications
No indication recorded.